TSHA•benzinga•
Taysha Gene Therapies Announces Details Of Its Part B Trial Design For TSHA-102; Announces Clinical Data From Part A Of REVELA Phase 1/2 Adolescent/Adult And Pediatric Trials Evaluating TSHA-102 In Rett Syndrome
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 28, 2025 by benzinga